BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 17560959)

  • 21. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables.
    Thieme K; Turk DC; Flor H
    Psychosom Med; 2004; 66(6):837-44. PubMed ID: 15564347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suicidal ideation and anxiety disorders: elevated risk or artifact of comorbid depression?
    Norton PJ; Temple SR; Pettit JW
    J Behav Ther Exp Psychiatry; 2008 Dec; 39(4):515-25. PubMed ID: 18294614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Components of self-esteem in affective patients and non-psychiatric controls.
    Serretti A; Olgiati P; Colombo C
    J Affect Disord; 2005 Sep; 88(1):93-8. PubMed ID: 16040127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depression and anxiety disorders in pediatric epilepsy.
    Caplan R; Siddarth P; Gurbani S; Hanson R; Sankar R; Shields WD
    Epilepsia; 2005 May; 46(5):720-30. PubMed ID: 15857439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders.
    König HH; Roick C; Angermeyer MC
    Eur Psychiatry; 2007 Apr; 22(3):177-87. PubMed ID: 17142014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tridimensional personality questionnaire factors in major depressive disorder: relationship to anxiety disorder comorbidity and age of onset.
    Ongur D; Farabaugh A; Iosifescu DV; Perlis R; Fava M
    Psychother Psychosom; 2005; 74(3):173-8. PubMed ID: 15832068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of traumatic and violent victimization experiences in individuals with schizophrenia and schizoaffective disorder.
    Newman JM; Turnbull A; Berman BA; Rodrigues S; Serper MR
    J Nerv Ment Dis; 2010 Oct; 198(10):708-14. PubMed ID: 20921860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Self-rating scales in schizophrenia: validity assessment of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogy scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(2):293-314. PubMed ID: 12776660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-stigma, self-esteem and age in persons with schizophrenia.
    Werner P; Aviv A; Barak Y
    Int Psychogeriatr; 2008 Feb; 20(1):174-87. PubMed ID: 17451617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible link between childhood separation anxiety and adulthood personality disorder in patients with anxiety disorders in Japan.
    Osone A; Takahashi S
    J Clin Psychiatry; 2006 Sep; 67(9):1451-7. PubMed ID: 17017834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychotic-like experiences in major depression and anxiety disorders: a population-based survey in young adults.
    Varghese D; Scott J; Welham J; Bor W; Najman J; O'Callaghan M; Williams G; McGrath J
    Schizophr Bull; 2011 Mar; 37(2):389-93. PubMed ID: 19687152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
    Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
    Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study.
    Hanel G; Henningsen P; Herzog W; Sauer N; Schaefert R; Szecsenyi J; Löwe B
    J Psychosom Res; 2009 Sep; 67(3):189-97. PubMed ID: 19686874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lifetime comorbidity of obsessive-compulsive disorder with psychiatric disorders in a community sample.
    Mohammadi MR; Ghanizadeh A; Moini R
    Depress Anxiety; 2007; 24(8):602-7. PubMed ID: 17152061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depressive experiences in inpatients with borderline personality disorder.
    Levy KN; Edell WS; McGlashan TH
    Psychiatr Q; 2007 Jun; 78(2):129-43. PubMed ID: 17347875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
    Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
    J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-morbid social phobia in schizophrenia.
    Mazeh D; Bodner E; Weizman R; Delayahu Y; Cholostoy A; Martin T; Barak Y
    Int J Soc Psychiatry; 2009 May; 55(3):198-202. PubMed ID: 19383663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression.
    Sim K; Mahendran R; Siris SG; Heckers S; Chong SA
    Psychiatry Res; 2004 Dec; 129(2):141-7. PubMed ID: 15590041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.